Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systematic amphetamine
References (41)
- et al.
Topography of substantia nigra innervation by D1 receptor-containing striatal neurons
Brain Research
(1987) - et al.
[3H]SCH23390 binding to D1 dopamine receptors in the basal ganglia of the cat and primate: Delineation of striosomal compartments and pallidal and nigral subdivisions
Neuroscience
(1988) - et al.
The D1 dopamine receptor antagonist SCH-23390 also interacts potently with brain serotonin (5-HT2) receptors
Eur. J. Pharmacol.
(1986) - et al.
Neurophysiological evidence that D1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists
Eur. J. Pharmacol.
(1986) - et al.
The pharmacological and anatomical substrates of the amphetamine response in the rat
Brain Research
(1975) - et al.
The D1 dopamine receptor in the rat brain: quantitative autoradiographic localization using an iodinated ligand
Neuroscience
(1988) - et al.
Studies on the relationship of tyrosine hydroxylase, dopamine and cyclic AMP-regulated phosphoprotein-32 immunoreactive neuronal structures and D1 receptor antagonist binding sites in various brain regions of the male rat — mismatches indicate a role of D1 receptors in volume transmission
Neurochem. Int.
(1988) - et al.
D-2 dopamine antagonist-like effects of SCH 23390 on A9 and A10 dopamine neurons
Life Sci.
(1987) - et al.
Effects of acute thioridazine, metoclopramide and SCH 23390 on the basal activity of A9 and A10 dopamine cells
Eur. J. Pharmacol.
(1987) - et al.
The D1 antagonist SCH 23390 stimulates while the D1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats
Eur.J. Pharmacol.
(1987)
Role of nigral dopamine in amphetamine-induced locomotor activity
Brain Research
(1983)
Effects of intranigra injections of dopamine agonists and antagonists, glycine, muscimol and N-methyl-d.l-aspartate on locomotor activity
Brain Res. Bull.
(1984)
Nigral reticula neurons: potentiation of responsiveness to amphetamine with long-term treatment
Brain Research
(1985)
Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine
Neuropharmacology
(1985)
Chronic amphetamine: is dopamine a link in or a mediator of the development of tolerance and reverse tolerance?
Pharmacol. Biochem. Behav.
(1981)
Dopamine D1 receptors in the nucleus accumbens: involvement in the reinforcing effect of tegmental stimulation
Brain Research
(1988)
Serotonergic component of SCH 23390: in vitro and in vivo binding analyses
Life Sci.
(1988)
SCH 23390, a selective dopamine D1 antagonist. Activates dopamine neurons but fails to prevent their inhibition by apomorphine
Eur. J. Pharmacol.
(1985)
The responses of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence
Brain Research
(1988)
3H-SCH 23390 binding sites in the rat substantia nigra: evidence for a presynaptic localization and innervation by dopamine
Life Sci.
(1986)
Cited by (0)
- *
Present address: Chaire de Neuropharmacologie, I.N.S.E.R.M. U114, College de France, 11 Place Marcelin Berthelot, 75231 Paris Cedex 5, France.
Copyright © 1989 Published by Elsevier B.V.